Request for Sample
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
The Nuclear Medicine Market report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2026.
The Nuclear Medicine Market report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint.
The global nuclear medicine market is segmented on the basis of product, application, and region.
Nuclear Medicine Market Overview:
The Nuclear Medicine Market was valued at $21.40 million in 2021 & is projected to reach $54.52 million by 2027. It is expected to grow at a 12.4% CAGR between 2021 and 2027.
Radioactive materials and isotopes used for the diagnosis and treatment of diseases such as neurological disorders, cancers, gastrointestinal, heart disease, etc. are known as nuclear medicines. Nuclear medicines help in the identification of diseases at an early stage by observing the molecular activity of cells within the body.
The increasing prevalence of cancer among individuals across the globe, coupled with increasing demand for accurate diagnosis and effective treatment by use of nuclear medicines are major factors driving the growth of the global nuclear medicine market.
In addition, increasing investments by governments and private sectors in the R&D of nuclear medicines and advanced diagnostic technology and systems is another factor driving the growth of the global market.
Major factors hampering the growth of the global nuclear medicine market are the high cost of diagnostic equipment and the high cost of treatment.
In addition, stringent government regulations for drug approval and drug usage are other factors hampering the growth of the target market.
However, the increasing application of nuclear medicine in neurological applications is expected to create lucrative opportunities for major manufacturers in the global market over the forecast period.
North America dominates the global nuclear medicine market in terms of revenue and is expected to maintain its dominance over the forecast period.
The presence of major manufacturers in this region and increasing investments by private players in the R&D of new and advanced diagnostics and treatment technologies and nuclear medicines are major factors contributing to the growth of the North American nuclear medicine market.
The Europe nuclear medicine market is expected to witness considerable growth and is expected to register a CAGR of X.X% over the next 10 years.
The market in the Asia Pacific is projected to witness the highest growth in terms of revenue, owing to the rapid development of healthcare infrastructure in countries such as India, China, etc.
Global Nuclear Medicine Market Segmentation:
Segmentation on the basis of product:
- Alpha Emitters
- Beta Emitters
Segmentation on the basis of application:
- Bone metastasis
- Endocrine tumor
Segmentation on the basis of region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Cardinal Health Inc.
- Eckert & Ziegler Group
- GE Healthcare
- Lantheus Medical Imaging Inc.
- Bayer AG
- Bracco Imaging S.p.A
- Eczacibasi-Monrol Nuclear Products
- Advanced Accelerator Applications S.A.
- Mallinckrodt Pharmaceuticals
- Jubilant Life Sciences
- NTP Radioisotopes SOC Ltd.
Request for TOC
Don't just take our word. We are trusted by these great companies!